Product Information
QUILLIVANT XR 25 MG/5 ML SUSP is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $2.7014 per ML under NDC 24478032204. Its NADAC has been published 409 times since Oct 24, 2018.
FDA first approved this application on Sep 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/120mL
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478032204
Classification
Brand
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA202100FDA Approved
9/27/2012
TE Code
AB
On Market Since
10/1/2012
Pharmacological Classes
Price Statistics
The NADAC for QUILLIVANT XR 25 MG/5 ML SUSP has been published 409 times since Oct 24, 2018, and over the history we have for it it has risen 23.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7014 per ML |
|---|---|
| All-time high | $2.7176 (Mar 15, 2023) |
| All-time low | $2.1821 (Oct 24, 2018) |
| 52-week high | $2.7063 |
| 52-week low | $2.7013 |
| Median price | $2.7022 |
| Average price | $2.5991 |
| Largest weekly change | +9.9% (Jan 8, 2020) |
| Weeks tracked | 409 |
| Tracking since | Oct 24, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUILLIVANT XR 25 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for QUILLIVANT XR 25 MG/5 ML SUSP, manufactured by NextWave Pharmaceuticals, Inc, is $2.7014 per ML (NDC 24478032204), effective Aug 19, 2026.
How has the price of QUILLIVANT XR 25 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for QUILLIVANT XR 25 MG/5 ML SUSP has risen 23.8%. It has been tracked across 409 weekly CMS publications since Oct 24, 2018.
What are the highest and lowest recorded NADAC prices for QUILLIVANT XR 25 MG/5 ML SUSP?
Since Oct 24, 2018, the NADAC for QUILLIVANT XR 25 MG/5 ML SUSP has ranged from a low of $2.1821 (Oct 24, 2018) to a high of $2.7176 (Mar 15, 2023), with a median of $2.7022 per ML.
Are there cheaper alternatives to QUILLIVANT XR 25 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of QUILLIVANT XR 25 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUILLIVANT XR 25 MG/5 ML SUSP?
QUILLIVANT XR 25 MG/5 ML SUSP (NDC 24478032204) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.